Briacell Therapeutics Corp (BCTXW:NASDAQ)

$0.0021 -0.00 (-8.70%)

watchlist-icon
search-icon
Profile Icon

This Week's Average Sentiment Analysis Score (0 to 100): 67

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]

Change Analysis Timeline Daily Weekly Monthly subspinner

Analysed Briacell Therapeutics Corp (BCTXW:NASDAQ) News Sources

BriaCell, BriaPro ink asset purchase agreement for exclusive license to develop and commercialize soluble CD80

Pharmabiz

North American Morning Briefing: Markets Fall, Oil Surges on U.S.-Iran Fears -2-

Morningstar

BCTXW stock
BCTXW stock price
BCTXW stock price today
BCTXW stock prediction
BCTXW earnings date
BCTXW news
BCTXW price
BCTXW share
BCTXW share price
BCTXW shares
BCTXW ceo
BCTXW premarket
$BCTXW
BCTXW ticker
BCTXW after hours
BCTXW stock
BCTXW stock price
BCTXW stock price today
BCTXW stock prediction
BCTXW earnings date
BCTXW news
BCTXW price
BCTXW share
BCTXW share price
BCTXW shares
BCTXW ceo
BCTXW premarket
$BCTXW
BCTXW ticker
BCTXW after hours

Briacell Therapeutics Corp (BCTXW:NASDAQ) FAQs

toggle

What is the current price of Briacell Therapeutics Corp (BCTXW:NASDAQ)?

The current price of Briacell Therapeutics Corp (BCTXW:NASDAQ) is $0.0021.


toggle

Briacell Therapeutics Corp (BCTXW:NASDAQ) absolute price change since previous trading day?

The absolute price change of Briacell Therapeutics Corp (BCTXW:NASDAQ) since the previous trading day is $-0.00.


toggle

Briacell Therapeutics Corp (BCTXW:NASDAQ) percentage price change since previous trading day?

The percentage price change of Briacell Therapeutics Corp (BCTXW:NASDAQ) since the previous trading day is -8.70%.


toggle

What is This Week's average sentiment score for Briacell Therapeutics Corp (BCTXW:NASDAQ)?

This Week's average sentiment score for Briacell Therapeutics Corp (BCTXW:NASDAQ) is 67 out of 100.


toggle

What is This Week's average sentiment for Briacell Therapeutics Corp (BCTXW:NASDAQ)?

This Week's sentiment for Briacell Therapeutics Corp (BCTXW:NASDAQ) is .


Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.